PEDF inhibits VEGF-induced vascular leakage through binding to VEGFR2 in acute myocardial infarction

References

• Benskey, M. J., & Manfredsson, F. P. (2016). Lentivirus production and purification. Methods in Molecular Biology (Clifton, N.J.), 1382, 107–114. https://doi.org/10.1007/978-1-4939-3271-9_8
   PubMedGoogle Scholar
• Chiong, M., Wang, Z. V., Pedrozo, Z., Cao, D. J., Troncoso, R., Ibacache, M., Criollo, A., Nemchenko, A., Hill, J. A., & Lavandero, S. (2011). Cardiomyocyte death: Mechanisms and translational implications. Cell Death & Disease, 2(12), e244–e244. https://doi.org/10.1038/cddis.2011.130
   PubMedGoogle Scholar
• Contessotto, P., & Pandit, A. (2021). Therapies to prevent post-infarction remodelling: From repair to regeneration. Biomaterials, 275, 120906. https://doi.org/10.1016/j.biomaterials.2021.120906
   PubMed Web of Science ®Google Scholar
• Corada, M., Mariotti, M., Thurston, G., Smith, K., Kunkel, R., Brockhaus, M., Lampugnani, M. G., Martin-Padura, I., Stoppacciaro, A., Ruco, L., McDonald, D. M., Ward, P. A., & Dejana, E. (1999). Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proceedings of the National Academy of Sciences of the United States of America, 96(17), 9815–9820. https://doi.org/10.1073/pnas.96.17.9815
   PubMed Web of Science ®Google Scholar
• Galaup, A., Gomez, E., Souktani, R., Durand, M., Cazes, A., Monnot, C., Teillon, J., Le Jan, S., Bouleti, C., Briois, G., Philippe, J., Pons, S., Martin, V., Assaly, R., Bonnin, P., Ratajczak, P., Janin, A., Thurston, G., Valenzuela, D. M., … Germain, S. (2012). Protection against myocardial infarction and no-reflow through preservation of vascular integrity by angiopoietin-like 4. Circulation, 125(1), 140–149. https://doi.org/10.1161/CIRCULATIONAHA.111.049072
   PubMed Web of Science ®Google Scholar
• Gao, X., Zhang, H., Zhuang, W., Yuan, G., Sun, T., Jiang, X., Zhou, Z., Yuan, H., Zhang, Z., & Dong, H. (2014). PEDF and PEDF-derived peptide 44mer protect cardiomyocytes against hypoxia-induced apoptosis and necroptosis via anti-oxidative effect. Scientific Reports, 4(1), 5637. https://doi.org/10.1038/srep05637
   PubMedGoogle Scholar
• Gavard, J., & Gutkind, J. S. (2006). VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nature Cell Biology, 8(11), 1223–1234. https://doi.org/10.1038/ncb1486
   PubMed Web of Science ®Google Scholar
• Hausenloy, D. J., Chilian, W., Crea, F., Davidson, S. M., Ferdinandy, P., Garcia-Dorado, D., van Royen, N., Schulz, R., & Heusch, G. (2019). The coronary circulation in acute myocardial ischaemia/reperfusion injury: A target for cardioprotection. Cardiovascular Research, 115(7), 1143–1155. https://doi.org/10.1093/cvr/cvy286
   PubMed Web of Science ®Google Scholar
• He, X., Cheng, R., Benyajati, S., & Ma, J. X. (2015). PEDF and its roles in physiological and pathological conditions: Implication in diabetic and hypoxia-induced angiogenic diseases. Clinical Science (London, England: 1979), 128(11), 805–823. https://doi.org/10.1042/CS20130463
   PubMed Web of Science ®Google Scholar
• Ito, H. (2006). No-reflow phenomenon and prognosis in patients with acute myocardial infarction. Nature Clinical Practice. Cardiovascular Medicine, 3(9), 499–506. https://doi.org/10.1038/ncpcardio0632
   PubMedGoogle Scholar
• Johnston, E. K., Francis, M. K., & Knepper, J. E. (2015). Recombinant pigment epithelium-derived factor PEDF binds vascular endothelial growth factor receptors 1 and 2. In Vitro Cellular & Developmental Biology. Animal, 51(7), 730–738. https://doi.org/10.1007/s11626-015-9884-0
   PubMed Web of Science ®Google Scholar
• Juettner, V. V., Kruse, K., Dan, A., Vu, V. H., Khan, Y., Le, J., Leckband, D., Komarova, Y., & Malik, A. B. (2019). VE-PTP stabilizes VE-cadherin junctions and the endothelial barrier via a phosphatase-independent mechanism. The Journal of Cell Biology, 218(5), 1725–1742. https://doi.org/10.1083/jcb.201807210
   PubMed Web of Science ®Google Scholar
• King, C., & Hristova, K. (2019). Direct measurements of VEGF-VEGFR2 binding affinities reveal the coupling between ligand binding and receptor dimerization. The Journal of Biological Chemistry, 294(23), 9064–9075. https://doi.org/10.1074/jbc.RA119.007737
   PubMed Web of Science ®Google Scholar
• Kloner, R. A., King, K. S., & Harrington, M. G. (2018). No-reflow phenomenon in the heart and brain. American Journal of Physiology. Heart and Circulatory Physiology, 315(3), H550–H562. https://doi.org/10.1152/ajpheart.00183.2018
   PubMed Web of Science ®Google Scholar
• LeBlanc, M. E., Saez-Torres, K. L., Cano, I., Hu, Z., Saint-Geniez, M., Ng, Y. S., & D'Amore, P. A. (2019). Glycocalyx regulation of vascular endothelial growth factor receptor 2 activity. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 33(8), 9362–9373. https://doi.org/10.1096/fj.201900011R
   PubMed Web of Science ®Google Scholar
• Leppänen, V.-M., Prota, A. E., Jeltsch, M., Anisimov, A., Kalkkinen, N., Strandin, T., Lankinen, H., Goldman, A., Ballmer-Hofer, K., & Alitalo, K. (2010). Structural determinants of growth factor binding and specificity by VEGF receptor 2. Proceedings of the National Academy of Sciences of the United States of America, 107(6), 2425–2430. https://doi.org/10.1073/pnas.0914318107
   PubMed Web of Science ®Google Scholar
• Liu, D., Xu, H., Zhang, C., Xie, H., Yang, Q., Li, W., Tian, H., Lu, L., Xu, J.-Y., Xu, G., Liu, K., Sun, X., Xu, G.-T., & Zhang, J. (2020). Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway. Life Sciences, 259, 118273. https://doi.org/10.1016/j.lfs.2020.118273
   PubMed Web of Science ®Google Scholar
• Liu, X., Liu, Z., Chen, J., Zhu, L., Zhang, H., Quan, X., Yuan, Y., Miao, H., Huang, B., Dong, H., & Zhang, Z. (2019). Pigment epithelium-derived factor increases native collateral blood flow to improve cardiac function and induce ventricular remodeling after acute myocardial infarction. Journal of the American Heart Association, 8(22), e013323. https://doi.org/10.1161/JAHA.119.013323
   PubMed Web of Science ®Google Scholar
• Lu, P., Zhang, Y.-Q., Zhang, H., Li, Y.-F., Wang, X.-Y., Xu, H., Liu, Z.-W., Li, L., Dong, H.-Y., & Zhang, Z.-M. (2016). Pigment epithelium-derived factor (PEDF) improves ischemic cardiac functional reserve through decreasing hypoxic cardiomyocyte contractility through PEDF receptor (PEDF-R). Journal of the American Heart Association, 5(7), e003179. https://doi.org/10.1161/JAHA.115.003179
   PubMed Web of Science ®Google Scholar
• Maczewski, M., & Mackiewicz, U. (2008). Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+ handling in the post-infarction rat heart. Cardiovascular Research, 79(1), 42–51. https://doi.org/10.1093/cvr/cvn057
   PubMed Web of Science ®Google Scholar
• Maier, J. A., Martinez, C., Kasavajhala, K., Wickstrom, L., Hauser, K. E., & Simmerling, C. (2015). ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. Journal of Chemical Theory and Computation, 11(8), 3696–3713. https://doi.org/10.1021/acs.jctc.5b00255
   PubMed Web of Science ®Google Scholar
• Miao, H., Qiu, F., Huang, B., Liu, X., Zhang, H., Liu, Z., Yuan, Y., Zhao, Q., Zhang, H., Dong, H., & Zhang, Z. (2018). PKCalpha replaces AMPK to regulate mitophagy: Another PEDF role on ischaemic cardioprotection. Journal of Cellular and Molecular Medicine, 22(11), 5732–5742. https://doi.org/10.1111/jcmm.13849
   PubMed Web of Science ®Google Scholar
• Qiu, F., Yuan, Y., Luo, W., Gong, Y. S., Zhang, Z. M., Liu, Z. M., & Gao, L. (2022). Asiatic acid alleviates ischemic myocardial injury in mice by modulating mitophagy- and glycophagy-based energy metabolism. Acta Pharmacologica Sinica, 43(6), 1395–1407. https://doi.org/10.1038/s41401-021-00763-9
   PubMed Web of Science ®Google Scholar
• Qiu, F., Zhang, H., Yuan, Y., Liu, Z., Huang, B., Miao, H., Liu, X., Zhao, Q., Zhang, H., Dong, H., & Zhang, Z. (2018). A decrease of ATP production steered by PEDF in cardiomyocytes with oxygen-glucose deprivation is associated with an AMPK-dependent degradation pathway. International Journal of Cardiology, 257, 262–271. https://doi.org/10.1016/j.ijcard.2018.01.034
   PubMed Web of Science ®Google Scholar
• Rahman, H. N. A., Wu, H., Dong, Y., Pasula, S., Wen, A., Sun, Y., Brophy, M. L., Tessneer, K. L., Cai, X., McManus, J., Chang, B., Kwak, S., Rahman, N. S., Xu, W., Fernandes, C., Mcdaniel, J. M., Xia, L., Smith, L., Srinivasan, R. S., & Chen, H. (2016). Selective targeting of a novel Epsin-VEGFR2 interaction promotes VEGF-mediated angiogenesis. Circulation Research, 118(6), 957–969. https://doi.org/10.1161/CIRCRESAHA.115.307679
   PubMed Web of Science ®Google Scholar
• Simonovic, M., Gettins, P. G., & Volz, K. (2001). Crystal structure of human PEDF, a potent anti-angiogenic and neurite growth-promoting factor. Proceedings of the National Academy of Sciences of the United States of America, 98(20), 11131–11135. https://doi.org/10.1073/pnas.211268598
   PubMed Web of Science ®Google Scholar
• Smith, R. O., Ninchoji, T., Gordon, E., André, H., Dejana, E., Vestweber, D., Kvanta, A., & Claesson-Welsh, L. (2020). Vascular permeability in retinopathy is regulated by VEGFR2 Y949 signaling to VE-cadherin. eLife, 9, e54056. https://doi.org/10.7554/eLife.54056
   Web of Science ®Google Scholar
• Torp, M.-K., Ranheim, T., Schjalm, C., Hjorth, M., Heiestad, C. M., Dalen, K. T., Nilsson, P. H., Mollnes, T. E., Pischke, S. E., Lien, E., Vaage, J., Yndestad, A., & Stensløkken, K.-O. (2022). Intracellular complement component 3 attenuated ischemia-reperfusion injury in the isolated buffer-perfused mouse heart and is associated with improved metabolic homeostasis. Frontiers in Immunology, 13, 870811. https://doi.org/10.3389/fimmu.2022.870811
   PubMed Web of Science ®Google Scholar
• Weis, S., Shintani, S., Weber, A., Kirchmair, R., Wood, M., Cravens, A., McSharry, H., Iwakura, A., Yoon, Y.-S., Himes, N., Burstein, D., Doukas, J., Soll, R., Losordo, D., & Cheresh, D. (2004). Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction. The Journal of Clinical Investigation, 113(6), 885–894. https://doi.org/10.1172/jci20702
   PubMed Web of Science ®Google Scholar
• Yuan, Y., Huang, B., Miao, H., Liu, X., Zhang, H., Qiu, F., Liu, Z., Zhang, Y., Dong, H., & Zhang, Z. (2019). A “hibernating-like” viable state induced by lentiviral vector-mediated pigment epithelium-derived factor overexpression in rat acute ischemic myocardium. Human Gene Therapy, 30(6), 762–776. https://doi.org/10.1089/hum.2018.186
   PubMed Web of Science ®Google Scholar
• Yuan, Y., Liu, X., Miao, H., Huang, B., Liu, Z., Chen, J., Quan, X., Zhu, L., Dong, H., & Zhang, Z. (2019). PEDF increases GLUT4-mediated glucose uptake in rat ischemic myocardium via PI3K/AKT pathway in a PEDFR-dependent manner. International Journal of Cardiology, 283, 136–143. https://doi.org/10.1016/j.ijcard.2019.02.035
   PubMed Web of Science ®Google Scholar
• Zhang, H., Hui, H., Li, Z., Pan, J., Jiang, X., Wei, T., Cui, H., Li, L., Yuan, X., Sun, T., Liu, Z., Zhang, Z., & Dong, H. (2017). Pigment epithelium-derived factor attenuates myocardial fibrosis via inhibiting endothelial-to-mesenchymal transition in rats with acute myocardial infarction. Scientific Reports, 7(1), 41932. https://doi.org/10.1038/srep41932
   PubMedGoogle Scholar
• Zhang, H., Li, Z., Quan, X., Liu, X., Sun, T., Wei, T., Pan, J., Liu, Z., Wang, M., Dong, H., & Zhang, Z. (2022). Strategies to attenuate myocardial infarction and no-reflow through preservation of vascular integrity by pigment epithelium-derived factor. Human Gene Therapy, 33(5-6), 330–345. https://doi.org/10.1089/hum.2021.068
   PubMed Web of Science ®Google Scholar
• Zhang, H., Sun, T., Jiang, X., Yu, H., Wang, M., Wei, T., Cui, H., Zhuang, W., Liu, Z., Zhang, Z., & Dong, H. (2015). PEDF and PEDF-derived peptide 44mer stimulate cardiac triglyceride degradation via ATGL. Journal of Translational Medicine, 13(1), 68. https://doi.org/10.1186/s12967-015-0432-1
   PubMedGoogle Scholar
• Zhang, H., Wang, Z., Feng, S.-J., Xu, L., Shi, H.-X., Chen, L.-L., Yuan, G.-D., Yan, W., Zhuang, W., Zhang, Y.-Q., Zhang, Z.-M., & Dong, H.-Y. (2015). PEDF improves cardiac function in rats with acute myocardial infarction via inhibiting vascular permeability and cardiomyocyte apoptosis. International Journal of Molecular Sciences, 16(3), 5618–5634. https://doi.org/10.3390/ijms16035618
   PubMed Web of Science ®Google Scholar